Pediatric Oncology
Pediatric Oncology
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
59
Clinical Trials
Pediatric Oncology
Phase III
Enrolling
nct/study# NCT06401330 / COG-AREN2231
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Learn More
Pediatric Oncology
Phase III
Enrolling
nct/study# NCT05675410 / COG-AHOD2131
A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-Oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma
Learn More
Pediatric Oncology
Phase III
Enrolling
nct/study# NCT05304585 / COG-ARST2032
A Prospective Phase 3 Study of Patients With Newly Diagnosed Very Low-Risk and Low-Risk Fusion Negative Rhabdomyosarcoma
Learn More
Pediatric Oncology
N/A
Enrolling
Pediatric Oncology
Phase II
Enrolling
nct/study# NCT05289687 / ECOG-EA9213
A Phase II Study of Daratumumab-Hyaluronidase for Chemotherapy-Relapsed/Refractory Minimal Residual Disease (MRD) in T Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL)
Learn More
Pediatric Oncology
N/A
Enrolling
nct/study# NCT01790152 / COG-ALTE11C2
Health Effects after Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-related Cardiomyopathy
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.